Skip to content

Released Mar 31, 2014, after the close

10-K filed Mar 31, 2014, 90 days after period end · 0001144204-14-019383

Q4 2013 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net Income-$6.05MderivedN/M vs Q4 2012N/M vs Q3 2013
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$6,094,044N/M
Free Cash Flowderived-$5,393,743—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2013derived from reported figuresQ4 2012Q4 2011Q4 2010derived from reported figures
Net Income-$6.05M-$3.79M-$18.86M—
EPS Diluted—-$0.29-$1.52—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR